Samir Chandrakant Patel
CIK: 0001277966
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KLRS
Kalaris Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About PATEL SAMIR CHANDRAKANT
PATEL SAMIR CHANDRAKANT (SEC CIK 0001277966) files insider reports with the SEC as Director of Kalaris Therapeutics, Inc. (KLRS).
Signal8 holds 3 ownership filings by PATEL SAMIR CHANDRAKANT (1 Form 3, 2 Form 4), filed between Mar 18, 2025 and Apr 11, 2025. Those filings report 3 transactions, from Mar 18, 2025 to Apr 10, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on PATEL SAMIR CHANDRAKANT's filings is in PALO ALTO, CA.
Recent filings by PATEL SAMIR CHANDRAKANT
Other insiders filing for Kalaris Therapeutics, Inc. (KLRS)
- Vandekop Amy O'Leary, VP, Corporate Controller
- KEATING LAURIE, Director
- Bayko Liisa Ann, Chief Financial Officer
- Jovan-Embiricos Morana, Director
- Ferrara Napoleone, Director
- Hallal David, Director